{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:06:07Z","timestamp":1793912767167,"version":"4.8.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.semnephrol.2025.151657","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:43:30Z","timestamp":1752644610000},"page":"151657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gene\u2013Environment Interaction: Lessons From Complement-Mediated Kidney Disease"],"prefix":"10.1016","volume":"45","author":[{"given":"Nattawat","family":"Klomjit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Java","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.semnephrol.2025.151657_bib0001","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneph.2016.70","article-title":"Complement in disease: a defence system turning offensive","volume":"12","author":"Ricklin","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151657_bib0002","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","article-title":"New insights into the immune functions of complement","volume":"19","author":"Reis","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151657_bib0003","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrd4657","article-title":"Complement, a target for therapy in inflammatory and degenerative diseases","volume":"14","author":"Morgan","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151657_bib0004","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151657_bib0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clim.2015.08.009","article-title":"Applying complement therapeutics to rare diseases","volume":"161","author":"Reis","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101331","article-title":"Complement dysregulation in glomerulonephritis","volume":"45","author":"Kaartinen","year":"2019","journal-title":"Semin Immunol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151657_bib0007","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MNH.0000000000000872","article-title":"Complement detection in kidney biopsies - utility and challenges","volume":"32","author":"Tomaszewski","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0008","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.molimm.2020.10.015","article-title":"Complement-mediated kidney diseases","volume":"128","author":"Poppelaars","year":"2020","journal-title":"Mol Immunol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151657_bib0009","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41581-023-00766-1","article-title":"The role of complement in kidney disease","volume":"19","author":"Petr","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0010","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2215\/CJN.11830720","article-title":"Inherited kidney complement diseases","volume":"16","author":"Lemaire","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103216","article-title":"Balancing efficacy and safety of complement inhibitors","volume":"145","author":"Watanabe-Kusunoki","year":"2024","journal-title":"J Autoimmun"},{"issue":"10364","key":"10.1016\/j.semnephrol.2025.151657_bib0012","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/S0140-6736(22)01202-8","article-title":"Haemolytic uraemic syndrome","volume":"400","author":"Michael","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0013","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151657_bib0014","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ackd.2021.11.006","article-title":"Thrombotic microangiopathy syndromes: common ground and distinct frontiers","volume":"29","author":"Hanna","year":"2022","journal-title":"Adv Chronic Kidney Dis"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151657_bib0015","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151657_bib0016","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151657_bib0017","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.kint.2017.06.022","article-title":"A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome","volume":"93","author":"Huerta","year":"2018","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151657_bib0018","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI115314","article-title":"Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells","volume":"88","author":"Brooimans","year":"1991","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151657_bib0019","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ki.1996.344","article-title":"Regulated expression of complement factor B in the human kidney","volume":"50","author":"Welch","year":"1996","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","article-title":"The complement system","volume":"343","author":"Sarma","year":"2011","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-pathol-012615-044145","article-title":"Complement dysregulation and disease: insights from contemporary genetics","volume":"12","author":"Liszewski","year":"2017","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0022","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A journey through the lectin pathway of complement: MBL and beyond","volume":"274","author":"Garred","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0023","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0065-2776(08)60697-5","article-title":"The regulators of complement activation (RCA) gene cluster","volume":"45","author":"Hourcade","year":"1989","journal-title":"Adv Immunol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0024","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.iy.09.040191.002243","article-title":"Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster","volume":"9","author":"Liszewski","year":"1991","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151657_bib0025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 8","key":"10.1016\/j.semnephrol.2025.151657_bib0026","doi-asserted-by":"crossref","first-page":"I9","DOI":"10.1016\/j.vaccine.2008.11.021","article-title":"Complement factor H related proteins in immune diseases","volume":"26","author":"Skerka","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151657_bib0027","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.1701695","article-title":"Statistical validation of rare complement variants provides insights into the molecular basis of atypical hemolytic uremic syndrome and C3 glomerulopathy","volume":"200","author":"Osborne","year":"2018","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151657_bib0028","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0029","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1053\/j.ajkd.2016.10.006","article-title":"AJKD atlas of renal pathology: thrombotic microangiopathy","volume":"68","author":"Lusco","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151657_bib0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy: understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0031","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrneph.2014.217","article-title":"Histopathology of MPGN and C3 glomerulopathies","volume":"11","author":"Cook","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151657_bib0032","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0033","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2215\/CJN.09541010","article-title":"Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees","volume":"6","author":"Athanasiou","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151657_bib0034","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ekir.2023.11.025","article-title":"Defining nephritic factors as diverse drivers of systemic complement dysregulation in C3 glomerulopathy","volume":"9","author":"Hauer","year":"2024","journal-title":"Kidney Int Reports"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ekir.2024.09.017","article-title":"Challenges in the diagnosis and management of immune complex-mediated membranoproliferative glomerulonephritis and Complement 3 glomerulopathy","volume":"10","author":"Bomback","year":"2025","journal-title":"Kidney Int Reports"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151657_bib0036","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/1744666X.2020.1745063","article-title":"Revisiting the complement system in systemic lupus erythematosus","volume":"16","author":"Sharma","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2025.151657_bib0037","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1186\/ar586","article-title":"Complement and systemic lupus erythematosus","volume":"4","author":"Walport","year":"2002","journal-title":"Arthritis Res"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0038","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1086\/518257","volume":"80","author":"Yang","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0039","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fimmu.2016.00036","article-title":"Early components of the complement classical activation pathway in human systemic autoimmune diseases","volume":"7","author":"Lintner","year":"2016","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0040","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3899\/jrheum.220752","article-title":"The role of complement in autoimmune disease-associated thrombotic microangiopathy and the potential for therapeutics","volume":"50","author":"Java","year":"2023","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151657_bib0041","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar4016","article-title":"Factor H autoantibodies and deletion of complement factor H-related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome","volume":"14","author":"Foltyn Zadura","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0042","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semarthrit.2018.11.005","article-title":"Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: case series and review of literature","volume":"49","author":"Kello","year":"2019","journal-title":"Sem Arthritis Rheumatism"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0043","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.kint.2023.06.032","article-title":"Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification","volume":"104","author":"Sethi","year":"2023","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0044","first-page":"676","article-title":"Histology and immunohistology of IgA nephropathy","volume":"18","author":"Haas","year":"2005","journal-title":"J Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151657_bib0045","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1681\/ASN.2014010096","article-title":"Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy","volume":"26","author":"Zhu","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0046","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.kint.2018.02.023","article-title":"Circulating complement factor H\u2013related protein 5 levels contribute to development and progression of IgA nephropathy","volume":"94","author":"Zhu","year":"2018","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0047","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrneph.2017.37","article-title":"Complement in ANCA-associated vasculitis: mechanisms and implications for management","volume":"13","author":"Chen","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151657_bib0048","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s10875-008-9268-2","article-title":"Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis","volume":"29","author":"Xing","year":"2009","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0049","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2012.313","article-title":"Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"83","author":"Gou","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151657_bib0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: functional roles, genetic variations and disease associations","volume":"41","author":"Rodr\u00edguez de C\u00f3rdoba","year":"2004","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03552.x","article-title":"Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H","volume":"151","author":"de C\u00f3rdoba","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151657_bib0052","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151657_bib0053","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1093\/ndt\/gfq010","article-title":"Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS)","volume":"25","author":"Westra","year":"2010","journal-title":"Nephrol Dialysis Transplant"},{"issue":"22","key":"10.1016\/j.semnephrol.2025.151657_bib0054","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood.2021012037","article-title":"Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification","volume":"138","author":"Mart\u00edn Merinero","year":"2021","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.semnephrol.2025.151657_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914496","article-title":"Underlying genetics of aHUS: which connection with outcome and treatment discontinuation?","volume":"24","author":"Spasiano","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0056","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12920-015-0115-z","article-title":"Defining \u201cmutation\u201d and \u201cpolymorphism\u201d in the era of personal genomics","volume":"8","author":"Karki","year":"2015","journal-title":"BMC Med Genomics"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151657_bib0057","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/jmg.2005.030783","article-title":"The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts","volume":"42","author":"Fremeaux-Bacchi","year":"2005","journal-title":"J Med Genetics"},{"issue":"22","key":"10.1016\/j.semnephrol.2025.151657_bib0058","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome","volume":"100","author":"Richards","year":"2003","journal-title":"Proc Nat Acad Sci"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151657_bib0059","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nefro.2021.07.003","article-title":"Contribution of functional and quantitative genetic variants of complement factor H and factor H-related (FHR) proteins on renal pathology","volume":"42","author":"G\u00f3mez Delgado","year":"2022","journal-title":"Nefrolog\u00eda"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0060","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J Experim Med"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0061","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fimmu.2018.00848","article-title":"High complement factor H-related (FHR)-3 levels are associated with the atypical hemolytic-uremic syndrome-risk allele CFHR3*B","volume":"9","author":"Pouw","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0062","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/344515","article-title":"Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome","volume":"71","author":"S\u00e1nchez-Corral","year":"2002","journal-title":"Am J Hum Genetics"},{"issue":"22","key":"10.1016\/j.semnephrol.2025.151657_bib0063","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood.2021012037","article-title":"Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification","volume":"138","author":"Mart\u00edn Merinero","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151657_bib0064","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ophtha.2011.07.056","article-title":"Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration","volume":"119","author":"Smailhodzic","year":"2012","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151657_bib0065","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250042","article-title":"Complement, complosome, and complotype: a perspective","volume":"53","author":"Singh","year":"2023","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151657_bib0066","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.it.2012.06.001","article-title":"The complotype: dictating risk for inflammation and infection","volume":"33","author":"Harris","year":"2012","journal-title":"Trends Immunol"},{"issue":"19","key":"10.1016\/j.semnephrol.2025.151657_bib0067","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2009-05-223834","article-title":"Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome","volume":"114","author":"Abarrategui-Garrido","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151657_bib0068","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome","volume":"68","author":"P\u00e9rez-Caballero","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151657_bib0069","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152164","article-title":"Complement factor H-related protein 3 serum levels are low compared to factor H and mainly determined by gene copy number variation in CFHR3","volume":"11","author":"Pouw","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151657_bib0070","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","article-title":"Atypical haemolytic uraemic syndrome associated with a hybrid complement gene","volume":"3","author":"Venables","year":"2006","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151657_bib0071","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1046\/j.1523-1755.1998.00130.x","article-title":"Complement regulatory proteins in glomerular diseases","volume":"54","author":"Nangaku","year":"1998","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151657_bib0072","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.molimm.2006.08.024","article-title":"Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome","volume":"44","author":"Liszewski","year":"2007","journal-title":"Mol Immunol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151657_bib0073","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20140117","article-title":"New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3","volume":"34","author":"Rodriguez","year":"2014","journal-title":"Biosci Rep"},{"issue":"1-3","key":"10.1016\/j.semnephrol.2025.151657_bib0074","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molimm.2006.07.004","article-title":"Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome","volume":"44","author":"Richards","year":"2007","journal-title":"Mol Immunol"},{"issue":"17","key":"10.1016\/j.semnephrol.2025.151657_bib0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713041","article-title":"The rationale of complement blockade of the MCP(ggaac) haplotype following atypical hemolytic uremic syndrome of three Southeastern European countries with a literature review","volume":"24","author":"Turudic","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151657_bib0076","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1600-6143.2007.01888.x","article-title":"Recurrence of HUS due to CD46\/MCP mutation after renal transplantation: a role for endothelial microchimerism","volume":"7","author":"Fr\u00e9meaux-Bacchi","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0077","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3389\/fimmu.2020.01348","article-title":"The relevance of the MCP risk polymorphism to the outcome of aHUS associated with C3 mutations: a case report","volume":"11","author":"Lumbreras","year":"2020","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151657_bib0078","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Human Mol Genetics"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0079","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood.2022019361","article-title":"Mutations in atypical hemolytic uremic syndrome provide evidence for the role of calcium in complement factor I","volume":"142","author":"Java","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molimm.2007.05.004","article-title":"Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome","volume":"45","author":"Kavanagh","year":"2008","journal-title":"Mol Immunol"},{"issue":"15","key":"10.1016\/j.semnephrol.2025.151657_bib0081","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1182\/blood-2014-10-609073","article-title":"Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome","volume":"125","author":"Schramm","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151657_bib0082","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molimm.2015.03.248","article-title":"The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome","volume":"66","author":"Mart\u00ednez-Barricarte","year":"2015","journal-title":"Mol Immunol"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151657_bib0084","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molimm.2005.06.041","article-title":"Does complement factor B have a role in the pathogenesis of atypical HUS?","volume":"43","author":"Kavanagh","year":"2006","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151657_bib0086","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00467-009-1415-3","article-title":"A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome","volume":"25","author":"Tawadrous","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0087","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10875-014-0058-8","article-title":"A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome","volume":"34","author":"Funato","year":"2014","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151657_bib0088","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00296-022-05260-8","article-title":"Secondary immune-mediated thrombotic thrombocytopenic purpura in idiopathic inflammatory myopathy: a case-based review","volume":"43","author":"Ruffer","year":"2023","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151657_bib0089","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.ekir.2024.05.016","article-title":"Thrombotic microangiopathy in pregnancy: current understanding and management strategies","volume":"9","author":"Urra","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0090","article-title":"Pregnancy as a susceptible state for thrombotic microangiopathies","volume":"11","author":"Frimat","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151657_bib0091","article-title":"HELLP syndrome and differential diagnosis with other thrombotic microangiopathies in pregnancy","volume":"14","author":"Giannubilo","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151657_bib0092","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.seminhematol.2018.04.003","article-title":"Complement in pathophysiology and treatment of transplant-associated thrombotic microangiopathies","volume":"55","author":"Jodele","year":"2018","journal-title":"Semin Hematol"},{"issue":"923","key":"10.1016\/j.semnephrol.2025.151657_bib0093","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/pmj.78.923.520","article-title":"HIV associated thrombotic microangiopathy","volume":"78","author":"Ahmed","year":"2002","journal-title":"Postgrad Med J"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0094","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrmicro2366","article-title":"Molecular mechanisms of complement evasion: learning from staphylococci and meningococci","volume":"8","author":"Serruto","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01450","article-title":"Viral evasion of the complement system and its importance for vaccines and therapeutics","volume":"11","author":"Mellors","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0096","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fmicb.2017.00213","article-title":"The complement system in flavivirus infections","volume":"8","author":"Conde","year":"2017","journal-title":"Front Microbiol."},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0097","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.4049\/jimmunol.181.6.4199","article-title":"Smallpox inhibitor of complement enzymes (SPICE): regulation of complement activation on cells and mechanism of its cellular attachment","volume":"181","author":"Liszewski","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151657_bib0098","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molimm.2014.06.004","article-title":"Viral regulators of complement activation: structure, function and evolution","volume":"61","author":"Ojha","year":"2014","journal-title":"Mol Immunol"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151657_bib0099","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/tri.12582","article-title":"Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature","volume":"28","author":"Java","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0100","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.3389\/fimmu.2018.02597","article-title":"Regulation of placental extravillous trophoblasts by the maternal uterine environment","volume":"9","author":"Pollheimer","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0101","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01681","article-title":"Essential role of complement in pregnancy: from implantation to parturition and beyond","volume":"11","author":"Girardi","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0102","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.03098","article-title":"Dysregulation of complement activation and placental dysfunction: a potential target to treat preeclampsia?","volume":"10","author":"Pierik","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151657_bib0103","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/1471-0528.17529","article-title":"Identification of complement factor H variants that predispose to pre-eclampsia: a genetic and functional study","volume":"130","author":"Lokki","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0104","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.preghy.2019.08.004","article-title":"Placenta derived factors involved in the pathogenesis of the liver in the syndrome of haemolysis, elevated liver enzymes and low platelets (HELLP): a review","volume":"18","author":"van Lieshout","year":"2019","journal-title":"Pregnancy Hypertens"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151657_bib0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10641955.2019.1640725","article-title":"Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia","volume":"38","author":"Yonekura Collier","year":"2019","journal-title":"Hypertens Pregnancy"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151657_bib0106","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13033","article-title":"Upregulation and release of soluble FMS-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells","volume":"80","author":"Banadakoppa","year":"2018","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151657_bib0107","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.kint.2019.05.014","article-title":"Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome","volume":"96","author":"Cavero","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151657_bib0109","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/HYPERTENSIONAHA.119.13714","article-title":"Diagnostic and risk factors for complement defects in hypertensive emergency and thrombotic microangiopathy","volume":"75","author":"Timmermans","year":"2020","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151657_bib0110","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2215\/CJN.05830518","article-title":"Complement gene variants and Shiga toxin\u2013producing Escherichia coli\u2013associated hemolytic uremic syndrome: retrospective genetic and clinical study","volume":"14","author":"Fr\u00e9meaux-Bacchi","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151657_bib0111","doi-asserted-by":"crossref","first-page":"E369","DOI":"10.1002\/ajh.27101","article-title":"Frequency and characteristics of chemotherapy-associated thrombotic microangiopathy: analysis from a large pharmacovigilance database","volume":"98","author":"Klomjit","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0112","article-title":"Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management","volume":"13","author":"Mazzierli","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0113","article-title":"The loss of glycocalyx integrity impairs complement factor H binding and contributes to cyclosporine-induced endothelial cell injury","volume":"10","author":"Teoh","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151657_bib0114","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151657_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101081","article-title":"Thrombotic microangiopathy in oncology: a review","volume":"14","author":"Val\u00e9rio","year":"2021","journal-title":"Transl Oncol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151657_bib0116","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.akdh.2023.09.003","article-title":"Thrombotic microangiopathies and the kidney","volume":"31","author":"Java","year":"2024","journal-title":"Adv Kidney Dis Health"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151657_bib0117","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/ndt\/gfac213","article-title":"Retrospective study of 59 cases of cancer-associated thrombotic microangiopathy: presentation and treatment characteristics","volume":"38","author":"Decaestecker","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151657_bib0118","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.ackd.2019.11.003","article-title":"Peri- and post-operative evaluation and management of atypical hemolytic uremic syndrome (aHUS) in kidney transplantation","volume":"27","author":"Java","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0119","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trre.2017.10.001","article-title":"De novo thrombotic microangiopathy after kidney transplantation","volume":"32","author":"Garg","year":"2018","journal-title":"Transplant Rev (Orlando)"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01487740","article-title":"Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells","volume":"20","author":"Foreman","year":"1996","journal-title":"Inflammation"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151657_bib0121","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.4049\/jimmunol.178.12.7911","article-title":"RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells","volume":"178","author":"Jin","year":"2007","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151657_bib0122","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200161","article-title":"Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle","volume":"10","author":"Dehghani","year":"2020","journal-title":"Open Biol"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151657_bib0123","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.1097\/TXD.0000000000001239","article-title":"Rejection-associated phenotype of de novo thrombotic microangiopathy represents a risk for premature graft loss","volume":"7","author":"Petr","year":"2021","journal-title":"Transplant Direct"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0124","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.582737","article-title":"Plasma C4d correlates with C4d deposition in kidneys and with treatment response in lupus nephritis patients","volume":"11","author":"Martin","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1357869","article-title":"Urinary complement biomarkers in immune-mediated kidney diseases","volume":"15","author":"Kesarwani","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2016.00055","article-title":"Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway","volume":"7","author":"Macedo","year":"2016","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151657_bib0127","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.ekir.2021.05.029","article-title":"The influence of an elastase-sensitive complement C5 variant on lupus nephritis and its flare","volume":"6","author":"Toy","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0128","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.semnephrol.2013.08.004","article-title":"The role of complement in membranous nephropathy","volume":"33","author":"Ma","year":"2013","journal-title":"Semin Nephrol"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151657_bib0129","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1681\/ASN.2021101384","article-title":"Complement C3a and C3a receptor activation mediates podocyte injuries in the mechanism of primary membranous nephropathy","volume":"33","author":"Gao","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151657_bib0130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2215\/CJN.09710913","article-title":"Association of C4d deposition with clinical outcomes in IgA nephropathy","volume":"9","author":"Espinosa","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151657_bib0131","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1038\/s41598-021-84715-7","article-title":"A multicenter, prospective, observational study to determine association of mesangial C1q deposition with renal outcomes in IgA nephropathy","volume":"11","author":"Tan","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151657_bib0132","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.xkme.2021.06.009","article-title":"Glomerular C4d deposition and kidney disease progression in IgA nephropathy: a systematic review and meta-analysis","volume":"3","author":"Jiang","year":"2021","journal-title":"Kidney Med"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0133","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.638309","article-title":"Alternative complement pathway is activated and associated with galactose-deficient IgA(1) antibody in IgA nephropathy patients","volume":"12","author":"Chiu","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151657_bib0134","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ekir.2019.06.008","article-title":"Glomerular complement factor H-related protein 5 (FHR5) is highly prevalent in C3 glomerulopathy and associated with renal impairment","volume":"4","author":"Medjeral-Thomas","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151657_bib0135","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2215\/CJN.02790313","article-title":"Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN","volume":"8","author":"Gou","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151657_bib0136","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2215\/CJN.0000000000000252","article-title":"Rare variants in complement gene in C3 glomerulopathy and immunoglobulin-mediated membranoproliferative GN","volume":"18","author":"Meuleman","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0137","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.3389\/fimmu.2018.02329","article-title":"Unraveling the molecular mechanisms underlying complement dysregulation by nephritic factors in C3G and IC-MPGN","volume":"9","author":"Donadelli","year":"2018","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151657_bib0138","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0139","unstructured":"Noris M, Bresin E, Mele C, Remuzzi G. Genetic atypical hemolytic-uremic syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae.University of Washington, Seattle"},{"key":"10.1016\/j.semnephrol.2025.151657_bib0140","unstructured":"Copyright \u00a9 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved, 1993."},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151657_bib0141","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1681\/ASN.2005101051","article-title":"Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome","volume":"17","author":"Fremeaux-Bacchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151657_bib0142","first-page":"400","article-title":"The genetics of atypical hemolytic uremic syndrome","volume":"30","author":"Feitz","year":"2018","journal-title":"Med Genet"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151657_bib0143","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ki.2009.472","article-title":"Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome","volume":"77","author":"Bienaime","year":"2010","journal-title":"Kidney Int"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T14:44:08Z","timestamp":1754664248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929525000956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":142,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0270929525000956"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151657","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene\u2013Environment Interaction: Lessons From Complement-Mediated Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151657"}}